Company News

Procter & Gamble Granted Cell Research License from Geron

Biopharmaceutical company Geron Corp., Menlo Park, CA, has granted a non-exclusive license to Procter & Gamble Company for Geron’s human telomerase reverse transcriptase technology in cell research applications. Financial terms of the agreement were not disclosed.

The technology will allow Procter & Gamble to conduct repeated or long-term studies on the biology and function of cells using hTERT technology, which proliferate indefinitely while maintaining normal physical and biological characteristics, according to reports.

Add us as a preferred source on Google

Get the latest Happi news, insights and analysis in your Google Search and AI experiences.

Keep Up With Our Content. Subscribe To Happi Newsletters